Skip to main content
. Author manuscript; available in PMC: 2023 Jun 12.
Published in final edited form as: SLAS Discov. 2022 Mar 17;27(3):159–166. doi: 10.1016/j.slasd.2022.03.002

Figure 5. MedChem EC50 data of the analog compounds.

Figure 5.

(A). Dose response assays of the analogs of SR-963 chemotype main lead were tested vs. 3D hT1 and hT1-CAF pancreatic cell lines. Data represent 10-point 3-fold serial dilutions starting at 5μM nominal concentration. (n=3 for each concentration tested). Error bars are included and shown in SD.